| Kenneth Galeckas, MD | |
|
100 Foden Road, West, Suite 100, South Portland, ME 04106 | |
| (207) 523-3900 | |
| Not Available |
| Full Name | Kenneth Galeckas |
|---|---|
| Gender | Male |
| Speciality | Micrographic Dermatologic Surgery (mds) |
| Experience | 28 Years |
| Location | 100 Foden Road, West, South Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659342558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 0101233289 (Virginia) | Secondary |
| 207N00000X | Dermatology | MD18763 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermed Pa | 5092605261 | 149 |
News Archive
Pharmarama, a leader in the strategic sourcing of comparator drugs for global clinical trials, today announced that the Massachusetts Department of Public Health has granted the company a Wholesale Distributor's License (WDL). The license enables Pharmarama to operate its pharmaceutical cold-chain and ambient storage and distribution facility in suburban Boston to provide extensive sourcing and comparator product storage services for its clients.
BioSante Pharmaceuticals, Inc. today announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for use in combination with Aduro's proprietary vaccine platform based on Listeria monocytogenes (Lm).
The American Academy of Family Physicians (AAFP) and the AAFP Foundation announce that they have been awarded a $150,000 grant from MetLife Foundation, designed to counter the national epidemic of childhood obesity by empowering family physicians with new ways to promote physical activity, nutrition and emotional well-being. The partnership will produce educational materials for children, including books and publications.
Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.
› Verified 6 days ago
| Entity Name | Intermed Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467422733 PECOS PAC ID: 5092605261 Enrollment ID: O20040319000548 |
News Archive
Pharmarama, a leader in the strategic sourcing of comparator drugs for global clinical trials, today announced that the Massachusetts Department of Public Health has granted the company a Wholesale Distributor's License (WDL). The license enables Pharmarama to operate its pharmaceutical cold-chain and ambient storage and distribution facility in suburban Boston to provide extensive sourcing and comparator product storage services for its clients.
BioSante Pharmaceuticals, Inc. today announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for use in combination with Aduro's proprietary vaccine platform based on Listeria monocytogenes (Lm).
The American Academy of Family Physicians (AAFP) and the AAFP Foundation announce that they have been awarded a $150,000 grant from MetLife Foundation, designed to counter the national epidemic of childhood obesity by empowering family physicians with new ways to promote physical activity, nutrition and emotional well-being. The partnership will produce educational materials for children, including books and publications.
Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth Galeckas, MD 100 Gannett Dr, Suite C, South Portland, ME 04106-5900 Ph: (207) 828-0361 | Kenneth Galeckas, MD 100 Foden Road, West, Suite 100, South Portland, ME 04106 Ph: (207) 523-3900 |
News Archive
Pharmarama, a leader in the strategic sourcing of comparator drugs for global clinical trials, today announced that the Massachusetts Department of Public Health has granted the company a Wholesale Distributor's License (WDL). The license enables Pharmarama to operate its pharmaceutical cold-chain and ambient storage and distribution facility in suburban Boston to provide extensive sourcing and comparator product storage services for its clients.
BioSante Pharmaceuticals, Inc. today announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for use in combination with Aduro's proprietary vaccine platform based on Listeria monocytogenes (Lm).
The American Academy of Family Physicians (AAFP) and the AAFP Foundation announce that they have been awarded a $150,000 grant from MetLife Foundation, designed to counter the national epidemic of childhood obesity by empowering family physicians with new ways to promote physical activity, nutrition and emotional well-being. The partnership will produce educational materials for children, including books and publications.
Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.
› Verified 6 days ago
Patrick M Benson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Rd. West, South Portland, ME 04106 Phone: 207-523-3900 Fax: 207-523-8593 | |
Dr. Christina E Killoran, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Rd, West, Suite 100, South Portland, ME 04106 Phone: 207-523-3900 Fax: 207-523-8593 | |
Kathy A Bush, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Road West, Suite 100, South Portland, ME 04106 Phone: 207-523-3900 Fax: 207-523-8593 | |
Dr. Joel A Sabean, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 350 Cottage Rd, South Portland, ME 04106 Phone: 207-767-2146 Fax: 207-799-1858 | |
Dr. Jessica M Kwock, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Rd., West, Suite 203, South Portland, ME 04106 Phone: 207-523-3900 Fax: 207-523-8593 | |
Thomas Samuel Bander, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 1, South Portland, ME 04106 Phone: 207-661-0100 |